<DOC>
	<DOCNO>NCT01013805</DOCNO>
	<brief_summary>The aim trial ( 1 ) determine tolerability rate set multi-centre study ( 2 ) determine secondary tolerability endpoint , toxicity rate complete pathologic response rate patient locally advanced rectal cancer treat integrated preoperative radiotherapy FOLFOX chemotherapy regimen .</brief_summary>
	<brief_title>Preoperative Radiotherapy Chemotherapy Patients With Locally Advanced Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Previously untreated pathologically proven adenocarcinoma rectum . MRI stag T3 T4 , N. Lower border tumour must within 12 cm anal verge . Age great equal 18 year . ECOG Performance Status 01 ( Appendix 2 ) Absolute neutrophil count great equal 1.5 x 109/L , haemoglobin great equal 90 g/L , platelet great equal 100 x 109/L . Adequate renal function : GFR great equal 55 mL/min ( derive serum creatinine e.g . use CockcroftGault formula measure radioisotopic technique ) . Bilirubin ALT less equal 1.5 x upper limit normal . No symptomatic peripheral neuropathy great equal grade 2 . Male nonpregnant , nonlactating female . Patients study reproductive potential , female partner reproductive potential , must use effective contraceptive . Has provide write informed consent participation trial Presence metastatic disease . Prior pelvic radiotherapy Febrile intercurrent illness infection . Previous history unstable angina Cardiac arrhythmia opinion investigator would compromise safe delivery protocol treatment Acute coronary syndrome even control medication Myocardial infarction within last 12 month Concurrent treatment anticancer therapy . Significant medical condition opinion investigator would compromise plan delivery chemotherapy radiotherapy may potentially exacerbated modality . Locally recurrent rectal cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Rectal Cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>